Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Compressing Drug Development Timelines with Accelerated Immunoassay

August 1, 2012

Recently developed immunoassay technology platforms reduce sample volume requirements and improve cycle times.

Pharmaceutical Dealmaking Broadens its Partnering Base

July 1, 2012

Collaborative R&D models coincide with new ways to fund translational research.

A 25-Year Retrospective on Bio-Engineering

July 1, 2012

Steven S. Kuwahara, PhD, principal consultant at GXP BioTechnology LLC, gives an update on "Engineering the Cell-System Interface."

Using a Systematic Approach to Select Critical Process Parameters

July 1, 2012

Harmonized regulations call for a risk-based and systematic approach to evaluating and selecting CPPs.

25 Years of Biopharmaceutical Innovation: An Expert Roundtable

June 1, 2012

Industry experts discuss significant achievements. Plus: What's in store for the future.

Developing Discoveries into New Therapeutics

June 1, 2012

Formulators and developers are at the heart of the industry's basic premise—they are saving lives.

Reducing Human Error

June 1, 2012

Leading industry collaborators outline top 10 best practices for human error reduction.

Creating a Product Portfolio from the Ground Up

June 1, 2012

Mike Clayman, CEO of Flexion Therapeutics, talks about his company's strategy to focus on a single therapeutic area.

Know the Regulations

June 1, 2012

The contract provider needs to know as much as the NDA holder.

ADVERTISEMENT

ADVERTISEMENT

Click here